The Boston-based firm sees the Sino-US rivalry and China’s regulatory tightening as major risks in the country.

The Boston-based firm sees the Sino-US rivalry and China’s regulatory tightening as major risks in the country.
The asset manager believes China is still “investable” and its tech companies provide good opportunities.
There are quality companies in China in sectors less impacted by regulation, according to Vontobel Asset Management.
Uncertainty has created discounted investment opportunities for stock pickers, according to Fidelity International.
With leading indicators for China suggesting only a temporary economic slowdown, there is reason for optimism in terms of the fixed income and equity markets, according to Pictet Asset Management (Pictet AM).
Indosuez Wealth Management (WM) expects risks to persist for Chinese equities.
The specialist Asia fund manager believes markets have overreacted to China’s regulatory crack down.
While China’s economic rebound stalls and the US economy holds steady, Invesco favours European and emerging market equities.
This week FSA presents a quick comparison of two China equities products: the Aberdeen Standard All China Equity Fund and the JP Morgan China Fund.
FSA compares two China equity products: The Schroder ISF China Opportunities Fund and the UBS (Lux) Equity Fund – China Opportunity Fund.
Part of the Mark Allen Group.